Stelexis' mission is to develop novel cancer drugs that selectively target critical pre-cancerous stem and progenitor cells leading to tumors. Our objective was communicating Stelexis’ unique value proposition in their corporate identity.

Our solution for Stelexis Therapeutics focused on communicating targeted treatment and leaving a recognizable impression of therapeutic improvement for cancer patients. The logo was intended to communicate simplicity & innovation.